Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency
    Bangning Yu, Jaime Becnel, Mourad Zerfaoui, Rasika Rohatgi, A. Hamid Boulares and Charles D. Nichols
    Journal of Pharmacology and Experimental Therapeutics November 2008, 327 (2) 316-323; DOI: https://doi.org/10.1124/jpet.108.143461
  • You have access
    Diarctigenin, a Lignan Constituent from Arctium lappa, Down-Regulated Zymosan-Induced Transcription of Inflammatory Genes through Suppression of DNA Binding Ability of Nuclear Factor-κB in Macrophages
    Byung Hak Kim, Seong Su Hong, Soon Woo Kwon, Hwa Young Lee, Hyeran Sung, In-Jeong Lee, Bang Yeon Hwang, Sukgil Song, Chong-Kil Lee, Daehyun Chung, Byeongwoo Ahn, Sang-Yoon Nam, Sang-Bae Han and Youngsoo Kim
    Journal of Pharmacology and Experimental Therapeutics November 2008, 327 (2) 393-401; DOI: https://doi.org/10.1124/jpet.108.140145
  • You have access
    7-Epiclusianone, a Tetraprenylated Benzophenone, Relaxes Airway Smooth Muscle through Activation of the Nitric Oxide-cGMP Pathway
    Luciana Pontes Coelho, Magda Fráguas Serra, Ana Lúcia de Aguiar Pires, Renato Sérgio Balão Cordeiro, Patrícia Machado Rodrigues e Silva, Marcelo Henrique dos Santos and Marco Aurélio Martins
    Journal of Pharmacology and Experimental Therapeutics October 2008, 327 (1) 206-214; DOI: https://doi.org/10.1124/jpet.108.138032
  • You have access
    Thiorphan-Induced Survival and Proliferation of Rat Thymocytes by Activation of Akt/Survivin Pathway and Inhibition of Caspase-3 Activity
    Consuelo Amantini, Michela Mosca, Roberta Lucciarini, Marina Cecilia Perfumi and Giorgio Santoni
    Journal of Pharmacology and Experimental Therapeutics October 2008, 327 (1) 215-225; DOI: https://doi.org/10.1124/jpet.108.138719
  • You have access
    Pharmacological Profile of JNJ-27141491 [(S)-3-[3,4-Difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl Acid Methyl Ester], as a Noncompetitive and Orally Active Antagonist of the Human Chemokine Receptor CCR2
    Mieke Buntinx, Bart Hermans, Jan Goossens, Dieder Moechars, Ron A. H. J. Gilissen, Julien Doyon, Staf Boeckx, Erwin Coesemans, Guy Van Lommen and Jean P. Van Wauwe
    Journal of Pharmacology and Experimental Therapeutics October 2008, 327 (1) 1-9; DOI: https://doi.org/10.1124/jpet.108.140723
  • You have access
    Fispemifene [Z-2-{2-[4-(4-Chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a Novel Selective Estrogen Receptor Modulator, Attenuates Glandular Inflammation in an Animal Model of Chronic Nonbacterial Prostatitis
    Emrah Yatkin, Jenni Bernoulli, Risto Lammintausta and Risto Santti
    Journal of Pharmacology and Experimental Therapeutics October 2008, 327 (1) 58-67; DOI: https://doi.org/10.1124/jpet.108.139501
  • You have access
    MF63 [2-(6-Chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation
    Daigen Xu, Steven E. Rowland, Patsy Clark, André Giroux, Bernard Côté, Sébastien Guiral, Myriam Salem, Yves Ducharme, Richard W. Friesen, Nathalie Méthot, Joseph Mancini, Laurent Audoly and Denis Riendeau
    Journal of Pharmacology and Experimental Therapeutics September 2008, 326 (3) 754-763; DOI: https://doi.org/10.1124/jpet.108.138776
  • You have access
    Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis I: Mechanistic Disease Progression Model for the Time Course of Collagen-Induced Arthritis in Lewis Rats
    Justin C. Earp, Debra C. DuBois, Diana S. Molano, Nancy A. Pyszczynski, Craig E. Keller, Richard R. Almon and William J. Jusko
    Journal of Pharmacology and Experimental Therapeutics August 2008, 326 (2) 532-545; DOI: https://doi.org/10.1124/jpet.108.137372
  • You have access
    Compounds That Increase or Mimic Cyclic Adenosine Monophosphate Enhance Tristetraprolin Degradation in Lipopolysaccharide-Treated Murine J774 Macrophages
    Ulla Jalonen, Erja-Leena Paukkeri and Eeva Moilanen
    Journal of Pharmacology and Experimental Therapeutics August 2008, 326 (2) 514-522; DOI: https://doi.org/10.1124/jpet.107.133702
  • You have access
    Integrated Cellular Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple Myeloma Patients
    Anshu Marathe, Mark C. Peterson and Donald E. Mager
    Journal of Pharmacology and Experimental Therapeutics August 2008, 326 (2) 555-562; DOI: https://doi.org/10.1124/jpet.108.137703

Pages

  • Previous
  • Next
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 36
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics